ImmunityBio, Inc. (NASDAQ:IBRX) Position Raised by Vanguard Group Inc.
Vanguard Group Inc. boosted its position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 2.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,328,229 shares of the company’s stock after purchasing an additional 425,713 shares during the period. Vanguard Group Inc.’s holdings in […]
Vanguard Group Inc. boosted its position in ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 2.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,328,229 shares of the company’s stock after purchasing an additional 425,713 shares during the period. Vanguard Group Inc.’s holdings in […]
